National Institute of Allergy and Infectious Diseases (NIAID)

🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers

NIAID has established a new pandemic preparedness research network, consisting of seven different research groups and one coordinating center. The Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network will conduct research on a representative virus or viruses within a specific virus family, with the goal of developing effective vaccines and monoclonal antibodies for other viruses within that family. Learn more: https://go.nih.gov/nhvf2ip

Whether you’re a current #NIAID researcher or applying for NIAID funding, it’s important to understand the expectations around data management and sharing. Review the NIAID and #NIH policies that govern data sharing and learn when, where, and how to share scientific data: https://go.nih.gov/ubDCTuA #NIAIDDataScience

Join the NIAID Office of Research Training & Development on September 18 for a virtual information session to learn more about Intramural NIAID Research Opportunities (INRO) 2025, a unique paid #postbaccalaureate research fellowship. Don’t miss this chance to get your questions answered and learn about the application process. Register at https://lnkd.in/ejgtYU4c   #NIAIDTraining #INRO2025

A #NIAID-supported study found increased #syphilis screening & diagnosis after opt-out syphilis tests were provided to people seeking care at a large emergency department. Most people diagnosed had no symptoms, which suggests that symptom-based testing strategies alone could miss opportunities to diagnose and treat people with syphilis. The results were published today in the journal Open Forum Infectious Diseases. Learn more: https://go.nih.gov/7ElQiqW UChicago Medicine

#NIAID researchers found that SARS-CoV-2—the virus that causes #COVID19—rapidly evolves in people with #HIV who have weakened immune systems. They used cutting-edge technology to examine genes from SARS-CoV-2 in people with and without HIV who also had COVID-19, looking at the different copies of the virus in individuals over time. They found that people with advanced HIV—as defined by reduced numbers of immune cells called CD4+ T cells—had dozens of SARS-CoV-2 variants in their bodies, compared to just one major variant in most people without HIV and people with HIV who had higher numbers of CD4+ T cells. The study revealed how some viral variants may emerge in people with weakened immune systems. Learn more at https://go.nih.gov/JNzEOGR

Do you need assistance with identifying and understanding a country's clinical trial requirements? The #NIAIDClinRegs site has been helping those involved in clinical research for the last 10 years! In the past year alone, nearly 68,000 users in 166 countries have visited ClinRegs. Check out a replay of our recent webinar to learn about what the site has to offer and how ClinRegs can help you: https://go.nih.gov/LYWD82S #ClinicalResearch

Fourteen vaginal bacterial species and the presence of a protein that promotes inflammation were associated with increased odds of HIV acquisition in a study of more than 500 cisgender women in South Africa, Uganda and Zimbabwe. The #NIAID-sponsored research was published in The Journal of Infectious Diseases. Learn more: https://go.nih.gov/k3hBj6t Fred Hutch University of Washington Magee-Womens Research Institute & Foundation University of Pittsburgh School of Medicine

We are hiring! 🔬 The #NIAID Transition Program in Clinical Research is seeking up to three assistant clinical investigators (physicians) for three- to five-year appointments. This program offers an exceptional opportunity to gain clinical and translational research experience within the NIAID Division of Intramural Research. In this role, you will work closely with senior NIAID investigators and have access to independent resources and staff. The program aims to increase the pool of well-trained clinical investigators who are competitive for clinical tenure-track positions. Learn more and #ApplyNow at https://go.nih.gov/2t4CYQt. Applications close 11/30. #NIAIDCareers #Research #NowHiring

🔬 The Preclinical Research and Development Branch (PRDB) in the Division of AIDS at #NIAID seeks applications from exceptional candidates for the supervisory health #scientist administrator (program officer) position to serve as chief of PRDB. This role offers the opportunity to lead a group of scientists who oversee a preclinical portfolio that supports research focused on the design and preclinical evaluation of #HIV and/or tuberculosis (#TB) vaccine candidates. In addition to engaging in the science of vaccine development, the PRDB chief works closely with staff to ensure a cohesive work unit, manage workloads, determine priorities, and perform appropriate personnel management activities. Be a part of advancing vaccine science and join NIAID’s mission to improve global health! Applications open 09/16. Learn more at https://go.nih.gov/Eusoj8O #JobOpening #NIAIDCareers